|
RLF expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.607700E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.747700E-02 |
| Normal-vs-Stage2 |
3.109000E-01 |
| Normal-vs-Stage3 |
1.391840E-01 |
| Normal-vs-Stage4 |
8.328200E-01 |
| Stage1-vs-Stage2 |
9.499600E-01 |
| Stage1-vs-Stage3 |
8.469600E-01 |
| Stage1-vs-Stage4 |
4.968800E-01 |
| Stage2-vs-Stage3 |
8.289200E-01 |
| Stage2-vs-Stage4 |
5.373400E-01 |
| Stage3-vs-Stage4 |
4.629400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.059360E-01 |
| Normal-vs-AfricanAmerican |
1.920010E-01 |
| Normal-vs-Asian |
8.422300E-02 |
| Caucasian-vs-AfricanAmerican |
9.078800E-01 |
| Caucasian-vs-Asian |
6.193400E-01 |
| AfricanAmerican-vs-Asian |
6.379800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.705790E-02 |
| Normal-vs-Female |
6.336200E-01 |
| Male-vs-Female |
1.257750E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
5.896600E-01 |
| Normal-vs-Extreme_Weight |
1.560010E-02 |
| Normal-vs-Obese |
4.863200E-01 |
| Normal-vs-Extreme_Obese |
1.175560E-01 |
| Normal_Weight-vs-Extreme_Weight |
3.438800E-01 |
| Normal_Weight-vs-Obese |
9.553200E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.185200E-01 |
| Extreme_Weight-vs-Obese |
1.565820E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.538800E-01 |
| Obese-vs-Extreme_Obese |
5.033400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.549200E-01 |
| Normal-vs-Age(41-60Yrs) |
9.082400E-01 |
| Normal-vs-Age(61-80Yrs) |
4.077700E-03 |
| Normal-vs-Age(81-100Yrs) |
1.918270E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.974400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.480950E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.000300E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.782600E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.228100E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.467800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.235200E-01 |
| Normal-VS-Type2 PRCC |
2.817300E-03 |
| Normal-VS-KIRP CIMP |
8.337800E-01 |
| Normal-VS-Unclassified PRCC |
9.036000E-01 |
| Type1 PRCC-VS-Type2 PRCC |
5.229600E-02 |
| Type1 PRCC-VS-KIRP CIMP |
4.138600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
3.977000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.211790E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
4.507700E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
7.903800E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.812100E-04 |
| Normal-vs-N1 |
6.326400E-01 |
| Normal-vs-N2 |
8.682800E-01 |
| N0-vs-N1 |
4.848300E-02 |
| N0-vs-N2 |
1.062780E-01 |
| N1-vs-N2 |
8.933600E-01 |
|
|
